Product Information

GAVILYTE-G SOLUTION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0046 per ML under NDC 43386009019. Its NADAC has been published 657 times since Nov 28, 2013.

GAVILYTE-G SOLUTION

polyethylene glycol-3350 and Electrolytes
$0.0046per ML

Strength

236; 2.97; 6.74; 5.86; 22.74 g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g

NDC

43386009019

Classification

Generic

Dosage Form

POWDER, FOR SOLUTION

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090231

On Market Since

6/1/2009

Pharmacological Classes

Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price Statistics

The NADAC for GAVILYTE-G SOLUTION has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 60.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0046 per ML
All-time high$0.0054 (Nov 16, 2022)
All-time low$0.0026 (Apr 18, 2018)
52-week high$0.0046
52-week low$0.0044
Median price$0.0030
Average price$0.0034
Largest weekly change+42.3% (Apr 20, 2022)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.2%

3M

+2.9%

6M

+4.7%

1Y

+0.9%

3Y

+4.7%

5Y

+64.5%

All

+60.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the polyethylene glycol-3350 and Electrolytes market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of GAVILYTE-G SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for GAVILYTE-G SOLUTION, manufactured by Lupin Pharmaceuticals Inc., is $0.0046 per ML (NDC 43386009019), effective Jun 24, 2026.

How has the price of GAVILYTE-G SOLUTION changed over time?

Over the history we have for it, the NADAC for GAVILYTE-G SOLUTION has risen 60.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GAVILYTE-G SOLUTION?

Since Nov 28, 2013, the NADAC for GAVILYTE-G SOLUTION has ranged from a low of $0.0026 (Apr 18, 2018) to a high of $0.0054 (Nov 16, 2022), with a median of $0.0030 per ML.

Are there cheaper alternatives to GAVILYTE-G SOLUTION?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GAVILYTE-G SOLUTION, so no direct lower-cost alternative is listed.

Who manufactures GAVILYTE-G SOLUTION?

GAVILYTE-G SOLUTION (NDC 43386009019) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.